HACKER SAFE certified sites prevent over 99.9% of hacker crime.
* Xplore *

*

Lung Cancer: Dana-Farber Cancer Institute Handbook

Click to enlarge photo

Lung Cancer: Dana-Farber Cancer Institute Handbook

5 stars from 1 review.

Authors: Arthur T. Skarin, Paul C. Lorigan

Availability:

RRP: £24.99
Our price: £20.74 (save 17%)
€25.93

This book appears in the following ReadMe Lists

* My Basket *

0 items

Total: £0.00

View Basket

 

* Tell a Friend *

Tell your friends about this book and we'll send each of you a gift voucher.



Overview Book details   Full details   Contents   Reviews


Overview

Part of a series of disease management handbooks designed to aid the clinician with decision making in clinical practice. This book provides a review of lung cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. It also gives diagnostic studies and clinical and pathological staging.


Book details

Format: Paperback
Pages: 168 pages
Height: 200mm
Width: 132mm
Weight: 222g
ISBN: 9780723434375 (0723434379)
Publication date: 29 June 2007
Edition: New title
Publisher: Elsevier Health Sciences
Country of publication: United Kingdom
Specialty: Oncology


Full details

Considerable progress is being made in the field of oncology, and the rapid expansion of available information can often make it difficult for the busy practitioner to know which decisions are most appropriate in a given circumstance. The success of the "Dana-Farber Cancer Institute Atlas of Diagnostic Oncology" has led to the development of a series of disease management handbooks designed to aid the clinician with his or her decision making in clinical practice. Written by highly eminent authors, each title is produced in full color and is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are also discussed in detail, particularly in relation to metastatic disease.


Contents

Introduction The role of molecular probes and other markers in the diagnosis and characterization of malignancy Lung cancer: aetiology, histopathology and clinical manifestation Lung cancer treatment Systemic and mucocutaneous reactions to chemotherapy


Reviews

1 review for this book. Read all reviews

Review excerts:

5 stars Great little book loved by the delegates at the ECCO 2007. Read full reviewright arrow


ReadMe Lists

1 ReadMe List contain s this book.

Oncology books - Cancer books Submitted by Xultbooks


isis logoidis logoverified by visa logomastercard secure code logo